Related Experiment Videos
Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme
Abstract:
Strategies have been developed to abrogate the aberrant expression of dominant oncogenes as a means to accomplish targeted tumor eradication. We have demonstrated previously the utility of this approach using a hammerhead ribozyme designed to cleave the mutant sequence in codon 12 of the activated H-ras oncogene transcript. To develop this strategy into a practical means to approach malignant disease, methods must be developed to accomplish high efficiency delivery of the ribozyme to target neoplastic cells. To accomplish this, a recombinant adenovirus was designed that encoded a gene cassette for the H-ras ribozyme. By using this virus, it was possible to accomplish high efficiency reversion of the neoplastic phenotype in mutant H-ras expressing tumor cells without the need for any selection steps. The demonstration of the utility of adenoviral-mediated delivery of anticancer ribozymes will allow the practical development of gene therapy strategies on this basis.
Insights
This study introduces a novel gene therapy approach using a recombinant adenovirus to deliver H-ras ribozymes. This method effectively targets and eradicates cancer cells by cleaving the H-ras oncogene transcript, offering a promising strategy for tumor eradication.
Area of Science:
- Molecular biology
- Gene therapy
- Oncology
Background:
- Aberrant oncogene expression drives tumor growth.
- Targeted tumor eradication strategies are crucial for cancer treatment.
- Ribozymes can specifically cleave oncogene transcripts.
Purpose of the Study:
- To develop an efficient delivery method for anticancer ribozymes.
- To investigate adenoviral-mediated delivery of H-ras ribozymes.
- To demonstrate targeted tumor eradication via gene therapy.
Main Methods:
- Designed a hammerhead ribozyme targeting H-ras oncogene codon 12.
- Constructed a recombinant adenovirus encoding the H-ras ribozyme gene cassette.
- Utilized the adenovirus for high-efficiency delivery to tumor cells.
Main Results:
- Achieved high-efficiency reversion of the neoplastic phenotype in H-ras expressing tumor cells.
- Demonstrated successful adenoviral-mediated delivery of ribozymes.
- No selection steps were required for phenotypic reversion.
Conclusions:
- Adenoviral-mediated delivery is an effective strategy for anticancer ribozymes.
- This approach enables practical development of gene therapy for malignant diseases.
- Targeted tumor eradication is achievable through oncogene-specific ribozyme delivery.